Showing results (1-10 of 1,283) with videos related to
Sort By:
Pageof 129
Pharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei KeTherapeutic Innovation & Regulatory Science|September 18, 2018
Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical TrialsHaijun Ma, Chunlei Ke, Qi Jiang, et al.Statistics in Medicine|February 21, 2012
Predicting analysis time in event-driven clinical trials with event-reporting lagJianming Wang, Chunlei Ke, Qi Jiang, et al.Therapeutic Innovation & Regulatory Science|September 18, 2018
Choosing Appropriate Metrics to Evaluate Adverse Events in Safety EvaluationYing Zhou, Chunlei Ke, Qi Jiang, et al.Statistics in Medicine|April 27, 2011
On the clinical meaningfulness of a treatment's effect on a time-to-event variableSteven Snapinn, Qi JiangJournal of Biopharmaceutical Statistics|June 22, 2013
Pure and hybrid causal effects on variables associated with an incident eventQi Jiang, Steven SnapinnTherapeutic Innovation & Regulatory Science|September 21, 2018
Remaining Challenges in Assessing Non-InferioritySteven Snapinn, Qi JiangPharmaceutical Statistics|September 30, 2011
Indirect comparisons in the comparative efficacy and non-inferiority settingsSteven Snapinn, Qi JiangStatistics in Medicine|October 5, 2007
Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trialsSteven Snapinn, Qi JiangStatistics in Medicine|October 5, 2007
Controlling the type 1 error rate in non-inferiority trialsSteven Snapinn, Qi JiangPageof 129